Plain-English translation of NCT06625684 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Glioblastoma research guide →This is an observational study — meaning researchers will follow your health over time rather than test a new medication or treatment. The study aims to understand what factors influence outcomes for people with glioblastoma, a serious type of brain tumor. By learning more about genetic, immune system, and personal health factors, researchers hope to develop better tools to predict outcomes and personalize care for future patients.
Glioblastoma is a very aggressive brain tumor, and doctors need better ways to understand which patients may have better or worse outcomes. This study exists to identify the key factors — biological, genetic, and medical — that affect how patients fare, so that treatment can be tailored to each person's situation.
You likely qualify if…
You likely don't qualify if…
You would be asked to complete online surveys about your health, medical history, and how you're doing over time. Researchers will also review your medical records and may collect biological samples (like blood) to analyze genetic and immune factors. There are no study visits to a clinic — everything is done remotely, making it convenient to participate while managing your health care.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
United States
Collaborators
Glioblastoma Research Organization, StacheStrong
Enrollment target
~200 participants
Started
December 2024
Primary completion
December 2029
Age range
18 Years and older
Last updated on clinicaltrials.gov in January 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Quinn Ostrom, PhD
Duke University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.